INIFY LABORATORIES AB
INIFY Laboratories AB provides cancer diagnostics services in Sweden. It offers prostate cancer diagnostics services. The company was incorporated in 2021 and is based in Stockholm, Sweden.
INIFY LABORATORIES AB (WY60) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, INIFY LABORATORIES AB (WY60) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
INIFY LABORATORIES AB - Net Assets Trend (None–None)
This chart illustrates how INIFY LABORATORIES AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for INIFY LABORATORIES AB (None–None)
The table below shows the annual net assets of INIFY LABORATORIES AB from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to INIFY LABORATORIES AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
INIFY LABORATORIES AB Competitors by Market Cap
The table below lists competitors of INIFY LABORATORIES AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bogala Graphite Lanka PLC
CM:BOGAN0000
|
$2.92K |
|
CTSA4F
SA:CTSA4F
|
$2.92K |
|
Thang Long Joint Stock Corp
VN:TTL
|
$2.92K |
|
Xy Labs Inc.
PINK:XYLB
|
$2.93K |
|
Lighthouse Hotel PLC
CM:LHLN0000
|
$2.92K |
|
ANGES MG
MU:AJW
|
$2.92K |
|
GeneThera Inc
PINK:GTHR
|
$2.92K |
|
QUICKSTEP HLDGS
BE:QIS
|
$2.92K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in INIFY LABORATORIES AB's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares INIFY LABORATORIES AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently INIFY LABORATORIES AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares INIFY LABORATORIES AB's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $10,792,710,184
- Average return on equity (ROE) among peers: -33.38%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| INIFY LABORATORIES AB (WY60) | €- | N/A | N/A | $2.92K |
| Spermosens AB (publ) (9R5) | $23.64 Million | -27.17% | 0.09x | $517.28K |
| BML Inc (BMZ) | $81.13 Billion | 8.19% | 0.43x | $462.01 Million |
| Genomic Vision Société Anonyme (G09) | $3.07 Million | -162.85% | 1.21x | $711.54K |
| ICON Public Limited Company (IJF) | $1.85 Billion | 17.96% | 0.86x | $6.58 Billion |
| Adicon Holdings Limited (K0U) | $1.77 Billion | 2.65% | 1.64x | $138.53 Million |
| WuXi XDC Cayman Inc. (L74) | $1.48 Billion | 10.52% | 0.69x | $2.05 Billion |
| NanoRepro AG (NN6) | $57.61 Million | 51.59% | 0.37x | $17.02 Million |
| PERRIGO (PGO) | $24.67 Million | -167.93% | 0.99x | $6.37K |